Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Business

EXPLAINED: Dr reddy s strategic vision reiterated following strong q1fy25 results | Rare Historical Photos

Dr. Reddy‘s Lab (Credit: Dr. Reddy's)

Dr. Reddy's Laboratories has kicked off FY25 with a strong performance, reflecting its strategic focus on diversified growth and long-term sustainability. The company's Q1FY25 earnings, announced on July 27, 2024, revealed a double-digit revenue growth, stable EBITDA margins, and a clear roadmap for future growth across multiple business segments.

A Robust Start to FY25

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.